Pediapharm Inc. (CVE:PDP – Get Free Report)’s share price traded up 1.7% during trading on Thursday. The stock traded as high as C$0.30 and last traded at C$0.30. Approximately 26,000 shares traded hands during trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.29.
Pediapharm Stock Performance
The stock has a 50 day moving average price of C$0.30 and a two-hundred day moving average price of C$0.30. The company has a current ratio of 1.12, a quick ratio of 0.71 and a debt-to-equity ratio of 186.87. The company has a market cap of C$66.36 million and a price-to-earnings ratio of -4.11.
About Pediapharm
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.
Read More
- Five stocks we like better than Pediapharm
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
